← back to fundSaaSVertical SaaS / Health· CAN

Pineapple Health Tech

Clinical workflow SaaS.

Cost basis $130.0M · Owns 28% · Last GP mark 2026-03-05

Synthetic equity

synth

$4B

80% CI $3B–$4B

Δ vs GP mark

+43.8%

+$1B

Synth revenue (TTM)

synth

$289M

Anchor $231M · 25.0%

Multiple applied

12.29x

Anchor 10.69x

Confidence

84%

Method: saas-traffic-headcount

Synthetic mark vs reported

Equity value, $M — band shows 80% confidence

SyntheticGP marksGround truth (sim)

Drivers vs anchor

log-elasticity decomposition · click a segment to isolate

Net +$1.6B

Synthetic mark is $1.6B above the anchor, driven by Paid account proxy (+96.8%) and Multiple momentum (+15.0%).

− $0.0M0+ $1.6B

Backtest vs ground truth

19 obs

R²

0.200

MAPE

29.9%

Lead vs GP

48d

Actual TTMEngine forecast

No alt-data anomalies in the last 30 days. Engine running clean.

Alt-data signals (trailing 12 months)

Inputs to the factor model

Headcount (engineering)

894

+120.2%

Talent panel · engineering FTE subset

Headcount (total)

2.1k

+121.2%

Talent panel · LinkedIn-derived FTE estimate

Paid account proxy

13.0k

+186.8%

Talent panel · job postings mentioning the product

Sessions (30d)

5.26M

+120.7%

Web panel · 30d trailing average

Tech-stack share

0.95

+44.4%

Tech-stack panel · install share

Web uniques (30d)

2.22M

+119.6%

Web panel · 30d trailing average